Literature DB >> 32025779

Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China.

Xuelian Liao1, Bo Wang1, Yan Kang2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32025779      PMCID: PMC7042184          DOI: 10.1007/s00134-020-05954-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
Up to 31 January 2020, there have been 9811 officially reported confirmed cases of 2019-novel coronavirus (nCoV) infection in China since the epidemic began in December 2019 (updated data available at https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6). With the rapid transmission, the epidemic has spread throughout the country, and 177 cases have been reported in Sichuan Province. As nCoV infection is a highly contagious disease with high mortality (3–15%) [1-3] and West China Hospital (WCH) is the largest hospital in the southwest of China and the referral medical center in Sichuan Province, it is our responsibility to prepare for admission of additional critically ill patients as a matter of emergency. We have held several expert meetings and have reviewed the related literature to develop a plan to respond to the epidemic [4, 5]. The purpose of the plan is to enable us to provide the maximum level of care to critically ill patients while ensuring the protection of medical staff.

Novel coronavirus infection special intensive care team

We set up a special emergency multi-disciplinary intensive care team to discuss the problems that we might encounter and countermeasures. Team members include intensive care unit (ICU) physician, infectious disease physician, nurse, respiratory therapist, nosocomial infection control expert, and administrative staff. We first evaluated the isolation conditions and the capacity of our department to admit a larger number of patients. Second, we specified the protection levels for different types of health care activities. Third, we assigned special work such as patient screening, consultation, and transfer to designated staff to minimize the number of health workers who had contact with patients with nCoV infection.

Bed and medical equipment preparation

WCH is a teaching hospital with 4300 total beds and 8 ICUs of total 206 ICU beds. Under normal conditions, the ICU bed usage is always above 90%. It was not appropriate to treat 2019-nCoV-infected patients in the central area because the large stream of people would have a negative impact on infection control measures to curb the spread of the infection. The hospital authorities decided to vacate 402 beds belonging to the Center of Infectious Disease and the adjacent Fifth Inpatient Building so that both are separated from the rest of the inpatient buildings in WCH (Supplementary Figure 1). Based on the initial data [1, 2] and taking into consideration the surge of critically ill patients, we plan to equip 50 ICU beds initially and adjust on the number of patients, as necessary. We made a list of requirements for other special medical equipment, such as ventilators, bronchoscopes, hemodialysis machines, ultrasound machines, standard personal protective equipment (PPE), and sterilizing equipment. During this epidemic period, a large amount of certified PPE, including medical masks, goggles, face shields, and waterproof isolation gowns, is required. Manufactures of the items on the requirement list were contracted and we drew up an advertisement to the society calling for donations to ensure sufficient supplies.

Education and training of staff

It is very important to make all staff aware of the public health significance of the epidemic, and of potential challenges in achieving disease control. Strict isolation and protection measures are a top priority. Training content includes hand and respiratory hygiene, use of PPE, safe waste management, environmental cleaning, and sterilization of patient-care equipment [6]. We educate and train staff by means of presentations, short videos, WeChat, and supervision to ensure that staff are following the correct procedures.

Protection of medical staff

A special access to patients was set up and a boundary between the ward in which the nCoV patients are being treated and the office and living area of medical staff was established. The aim was to minimize the number of medical staff that have contact with a patient at any time, including during daily care, treatment, and transfer; minimize the use of high transmission-risk procedures such as bronchoscopy, manual ventilation, non-invasive ventilation, and tracheotomy. We use airborne precautions if these operations are necessary. Diagnostic imaging procedures such as X-ray and ultrasound at the bedside are prioritized, restricting computed tomography (CT) scans, because they cannot be performed at the bedside.

Early case recognition and classification of disease severity

A physiological parameter-based warning score is used to facilitate early recognition of patients with severe infection and admission decisions according to the severity classification. The score is a modified version of the National Early Warning Score (NEWS) with age ≥ 65 years added as an independent risk factor based on recent reports [7, 8] (Fig. 1).
Fig. 1

Early warning score and rules for 2019-nCoV infected patients. *CCRRT: Critical Care Rapid Response Team

Early warning score and rules for 2019-nCoV infected patients. *CCRRT: Critical Care Rapid Response Team Patients are divided into four risk categories based on the score: low, median, high, and exceptional. A specially assigned physician or the special critical care team decides which patients need to be treated in the ICU, taking into consideration the disease severity, opportunity to benefit, and sources of support (Fig. 1).

Strict restriction of patient contact

All staff are required to report any history of exposure, respiratory symptoms, and temperature before entering the building in which the nCoV patients are treated. Everyone must wear masks, isolation suits, and wash hands if need to be in the building. Family members and non-essential medical staff are strictly forbidden from entering the nCoV ward.

Research

As nCoV infection is a novel disease, knowledge about it is limited [9, 10], especially regarding the management of critically ill patients. We designed a case report form to collect clinical data, proceed with the ethics committee approval of research protocols, and contact with the laboratory that is qualified to conduct research on highly infectious organisms. In conclusion, the 2019-nCoV epidemic is a threat, not only to China, but also to global health. As ICU physicians, our focus is on the management of the most severe patients. We are unable to predict how many critically ill patients we will receive but are doing the best that we can to be prepared and to work together to overcome the epidemic. Below is the link to the electronic supplementary material. Supplementary file1 (JPG 7082 kb)
  7 in total

1.  From SARS to Avian Influenza Preparedness in Hong Kong.

Authors:  Andrew T Y Wong; Hong Chen; Shao-Haei Liu; Enoch K Hsu; Kristine S Luk; Christopher K C Lai; Regina F Y Chan; Owen T Y Tsang; K W Choi; Y W Kwan; Anna Y H Tong; Vincent C C Cheng; Dominic N C Tsang
Journal:  Clin Infect Dis       Date:  2017-05-15       Impact factor: 9.079

2.  A Comparison of the Quick Sequential (Sepsis-Related) Organ Failure Assessment Score and the National Early Warning Score in Non-ICU Patients With/Without Infection.

Authors:  Oliver C Redfern; Gary B Smith; David R Prytherch; Paul Meredith; Matthew Inada-Kim; Paul E Schmidt
Journal:  Crit Care Med       Date:  2018-12       Impact factor: 7.598

3.  Coronavirus Infections-More Than Just the Common Cold.

Authors:  Catharine I Paules; Hilary D Marston; Anthony S Fauci
Journal:  JAMA       Date:  2020-02-25       Impact factor: 56.272

4.  A Risk Classification Model to Predict Mortality Among Laboratory-Confirmed Avian Influenza A H7N9 Patients: A Population-Based Observational Cohort Study.

Authors:  Leonardo Martinez; Wei Cheng; Xiaoxiao Wang; Feng Ling; Lan Mu; Changwei Li; Xiang Huo; Mark H Ebell; Haodi Huang; Limei Zhu; Chao Li; Enfu Chen; Andreas Handel; Ye Shen
Journal:  J Infect Dis       Date:  2019-10-22       Impact factor: 5.226

5.  Data sharing and outbreaks: best practice exemplified.

Authors:  David L Heymann
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 6.  Intensive Care Unit Preparedness During Pandemics and Other Biological Threats.

Authors:  Ryan C Maves; Christina M Jamros; Alfred G Smith
Journal:  Crit Care Clin       Date:  2019-07-12       Impact factor: 3.598

7.  A novel coronavirus outbreak of global health concern.

Authors:  Chen Wang; Peter W Horby; Frederick G Hayden; George F Gao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

  7 in total
  73 in total

1.  Bronchoalveolar lavage-detected SARS-CoV-2 infection in presence of serial negative nasopharyngeal swabs: a case report.

Authors:  Grazia Caci; Fabrizio Minervini; Carsten Fechner; Justus E Roos; Ellen C Obermann; Andrea Azzola
Journal:  Ann Transl Med       Date:  2021-04

2.  Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19.

Authors:  Ryan C Maves; Stephanie A Richard; David A Lindholm; Nusrat Epsi; Derek T Larson; Christian Conlon; Kyle Everson; Steffen Lis; Paul W Blair; Sharon Chi; Anuradha Ganesan; Simon Pollett; Timothy H Burgess; Brian K Agan; Rhonda E Colombo; Christopher J Colombo
Journal:  Open Forum Infect Dis       Date:  2021-08-10       Impact factor: 3.835

3.  Performance Analysis of the National Early Warning Score and Modified Early Warning Score in the Adaptive COVID-19 Treatment Trial Cohort.

Authors:  Christopher J Colombo; Rhonda E Colombo; Ryan C Maves; Angela R Branche; Stuart H Cohen; Marie-Carmelle Elie; Sarah L George; Hannah J Jang; Andre C Kalil; David A Lindholm; Richard A Mularski; Justin R Ortiz; Victor Tapson; C Jason Liang
Journal:  Crit Care Explor       Date:  2021-07-13

4.  Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study.

Authors:  David T Arnold; Marie Attwood; Shaney Barratt; Anna Morley; Karen T Elvers; Jorgen McKernon; Charmaine Donald; Adrian Oates; Alan Noel; Alasdair MacGowan; Nick A Maskell; Fergus W Hamilton
Journal:  Emerg Med J       Date:  2021-05-21       Impact factor: 2.740

5.  Global transmission network of SARS-CoV-2: from outbreak to pandemic.

Authors:  Pavel Skums; Alexander Kirpich; Pelin Icer Baykal; Alex Zelikovsky; Gerardo Chowell
Journal:  medRxiv       Date:  2020-03-27

6.  Tele-Nursing New Opportunity for Nursing Care in COVID-19 Pandemic Crisis.

Authors:  Majid Purabdollah; Mostafa Ghasempour
Journal:  Iran J Public Health       Date:  2020-10       Impact factor: 1.429

7.  The Prognostic Accuracy of National Early Warning Score 2 on Predicting Clinical Deterioration for Patients With COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Kai Zhang; Xing Zhang; Wenyun Ding; Nanxia Xuan; Baoping Tian; Tiancha Huang; Zhaocai Zhang; Wei Cui; Huaqiong Huang; Gensheng Zhang
Journal:  Front Med (Lausanne)       Date:  2021-07-09

8.  Spatial Statistics and Influencing Factors of the COVID-19 Epidemic at Both Prefecture and County Levels in Hubei Province, China.

Authors:  Yongzhu Xiong; Yunpeng Wang; Feng Chen; Mingyong Zhu
Journal:  Int J Environ Res Public Health       Date:  2020-05-31       Impact factor: 3.390

9.  Nurse Managers' Perceptions and Experiences during the COVID-19 Crisis: A Qualitative Study.

Authors:  Kolsoum Deldar; Razieh Froutan; Abbas Ebadi
Journal:  Iran J Nurs Midwifery Res       Date:  2021-05-17

10.  Modified National Early Warning Score as Early Predictor of Outcome in COVID-19 Pandemic.

Authors:  Fabio Tagliabue; Daniele Schena; Luca Galassi; Matteo Magni; Guglielmo Guerrazzi; Andrea Acerbis; Christina Rinallo; Daniel Longhi; Alberto Ronzani; Pierpaolo Mariani
Journal:  SN Compr Clin Med       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.